Urine steroid metabolomics as a diagnostic tool in primary aldosteronism. (2024)
Attributed to:
Selective CYP11B1 inhibitors as a novel treatment option for endogenous cortisol excess
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jsbmb.2023.106445
PubMed Identifier: 38104729
Publication URI: http://europepmc.org/abstract/MED/38104729
Type: Journal Article/Review
Volume: 237
Parent Publication: The Journal of steroid biochemistry and molecular biology
ISSN: 0960-0760